174 related articles for article (PubMed ID: 21747894)
1. Quality of life and related dimensions in cancer patients treated with mistletoe extract (iscador): a meta-analysis.
Büssing A; Raak C; Ostermann T
Evid Based Complement Alternat Med; 2012; 2012():219402. PubMed ID: 21747894
[TBL] [Abstract][Full Text] [Related]
2. Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review.
Ostermann T; Raak C; Büssing A
BMC Cancer; 2009 Dec; 9():451. PubMed ID: 20021637
[TBL] [Abstract][Full Text] [Related]
3. A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings.
Ostermann T; Appelbaum S; Poier D; Boehm K; Raak C; Büssing A
Complement Med Res; 2020; 27(4):260-271. PubMed ID: 31927541
[TBL] [Abstract][Full Text] [Related]
4. Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort Studies for Long-term Therapy of Breast Cancer Patients with a Mistletoe Preparation (Iscador).
Ziegler R; Grossarth-Maticek R
Evid Based Complement Alternat Med; 2010 Jun; 7(2):157-66. PubMed ID: 18955332
[TBL] [Abstract][Full Text] [Related]
5. Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.
Grossarth-Maticek R; Ziegler R
Eur J Med Res; 2006 Nov; 11(11):485-95. PubMed ID: 17182361
[TBL] [Abstract][Full Text] [Related]
6. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
[TBL] [Abstract][Full Text] [Related]
7. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
Grossarth-Maticek R; Ziegler R
Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
[TBL] [Abstract][Full Text] [Related]
8. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
[TBL] [Abstract][Full Text] [Related]
9. Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2007 Jun; 14(3):140-7. PubMed ID: 17596694
[TBL] [Abstract][Full Text] [Related]
10. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in cancer patients treated with mistletoe: a systematic review and meta-analysis.
Loef M; Walach H
BMC Complement Med Ther; 2020 Jul; 20(1):227. PubMed ID: 32690087
[TBL] [Abstract][Full Text] [Related]
12. Mistletoe therapy in oncology.
Horneber MA; Bueschel G; Huber R; Linde K; Rostock M
Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD003297. PubMed ID: 18425885
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles of different breast cancer cells compared with their responsiveness to fermented mistletoe (Viscum album L.) extracts Iscador from oak (Quercus), pine (Pinus), white fir (Abies) and apple tree (Malus) in vitro.
Eggenschwiler J; Patrignani A; Wagner U; Rehrauer H; Schlapbach R; Rist L; Ramos MH; Viviani A
Arzneimittelforschung; 2006 Jun; 56(6A):483-96. PubMed ID: 16927530
[TBL] [Abstract][Full Text] [Related]
15. Retrolective studies on the survival of cancer patients treated with mistletoe extracts: a meta-analysis.
Ostermann T; Büssing A
Explore (NY); 2012; 8(5):277-81. PubMed ID: 22938746
[TBL] [Abstract][Full Text] [Related]
16. Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.
Podlech O; Harter PN; Mittelbronn M; Pöschel S; Naumann U
Evid Based Complement Alternat Med; 2012; 2012():501796. PubMed ID: 23133496
[TBL] [Abstract][Full Text] [Related]
17. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
Urech K; Schaller G; Jäggy C
Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
[TBL] [Abstract][Full Text] [Related]
18. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study.
Bar-Sela G; Wollner M; Hammer L; Agbarya A; Dudnik E; Haim N
Eur J Cancer; 2013 Mar; 49(5):1058-64. PubMed ID: 23218588
[TBL] [Abstract][Full Text] [Related]
19. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
Büssing A
Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
[TBL] [Abstract][Full Text] [Related]
20. Survival of Cancer Patients Treated with Non-Fermented Mistletoe Extract: A Systematic Review and Meta-Analysis.
Loef M; Walach H
Integr Cancer Ther; 2022; 21():15347354221133561. PubMed ID: 36324298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
